Fondation Ophtalmologique Adolphe de Rothschild

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

4 drugs in development

Phase 32

Phase 22

Preclinical1

By Therapeutic Area

top 2

Cardiovascular

233%

Respiratory

117%

R&D Momentum

49/100

Pipeline Velocity

19/100

Trial Completion Rate

64/100

Pipeline Concentration

39/100

Pipeline Freshness

74/100

Strategic Signals

↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Jul 7, 2026

Completed

Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy

Jul 3, 2026

Completed

Measure of Specific Determinants of the Cerebral Small Vessel Disease in HIV+ Patients

Earlier

Mar 1, 2026TrialTreatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial

Jan 16, 2026TrialEfficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations

Jan 1, 2026TrialEfficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG Monitoring

Apr 29, 2025TrialImmediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.

Apr 1, 2025TrialEfficacy of Daily IV Administration of Dornase Alfa Up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence At 6 Months

Nov 9, 2023TrialImpact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial

4 more events

Aug 19, 2022TrialEfficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target)

Jul 1, 2022TrialInvestigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19

Mar 2, 2022TrialREperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts

Oct 19, 2021TrialMyopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)

Fondation Ophtalmologique Adolphe de Rothschild

Pipeline Snapshot

Recent Activity

Company Info

Drug Pipeline

Cardiovascular

Respiratory

Unknown / Other

Cardiovascular

Respiratory

Unknown / Other